In order to save patients suffering from undiagnosed HAE, the Diagnostic Consortium to Advance the Ecosystem for Hereditary Angioedema will collaborate with medical professionals, academic societies, patient groups, pharmaceutical companies and IT companies who deal with HAE patients on a daily basis, and aim to improve the appropriate early diagnosis and diagnosis rate through their expertise and creativity.
On May 20, 2021, tokyochips published an article about “the Diagnostic Consortium to Advance the Ecosystem for Hereditary Angioedema was established and will be fully operational”.
■Article
Please like and share this article.